medical guideline

首页 肿瘤学指南 输卵管癌 详情

The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

原文:2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 e49 浏览量:44 原文链接

作者: Japan Society of Gynecologic Oncology

归属分类: 所属人体系统: 生殖 | 分类:输卵管癌

关键词: The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.

指南简介

The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer